Deregulation of cell‐death pathways as the cornerstone of skin diseases

Deregulation of cell‐death pathways plays a key role in the pathogenesis of various skin diseases. The different types of cell death are mainly defined by morphological criteria, and include apoptosis, autophagic cell death, and necrosis. The process of apoptosis is well characterized at the molecular level and involves the activation of two main pathways, the intrinsic and extrinsic pathways, converging into the execution of apoptosis by intracellular cysteine proteases, called caspases. The relevance and implication of these apoptotic pathways in the pathophysiology of skin diseases, such as toxic epidermal necrolysis, graft‐versus‐host disease and skin cancer, has been extensively studied. The role of autophagic cell death in progression of skin tumours and response to cytotoxic drugs is only beginning to be elucidated.

[1]  V. Klump,et al.  Autophagy in cutaneous malignant melanoma , 2010, Journal of cutaneous pathology.

[2]  Claus Garbe,et al.  Melanoma epidemiology and trends. , 2009, Clinics in dermatology.

[3]  W. Urba,et al.  Efficient cross-presentation depends on autophagy in tumor cells. , 2008, Cancer research.

[4]  J. Lomas,et al.  The genetics of malignant melanoma. , 2008, Frontiers in bioscience : a journal and virtual library.

[5]  M. Wernli,et al.  Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. , 2008, Advances in experimental medicine and biology.

[6]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[7]  Robin Mathew,et al.  Role of autophagy in cancer , 2007, Nature Reviews Cancer.

[8]  J. Eberle,et al.  Low prevalence of p53, p16INK4a and Ha‐ras tumour‐specific mutations in low‐graded actinic keratosis , 2007, The British journal of dermatology.

[9]  L. Zitvogel,et al.  Cell death modalities: classification and pathophysiological implications , 2007, Cell Death and Differentiation.

[10]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[11]  L. Chin,et al.  Malignant melanoma: genetics and therapeutics in the genomic era. , 2006, Genes & development.

[12]  P. Agostinis,et al.  Pathways involved in sunburn cell formation: deregulation in skin cancer , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[13]  E. Barletta,et al.  The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens–Johnson syndrome/toxic epidermal necrolysis spectrum , 2006, The British journal of dermatology.

[14]  K. Niedojadło,et al.  Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi. , 2006, Pigment cell research.

[15]  W. Zong,et al.  Necrotic death as a cell fate. , 2006, Genes & development.

[16]  Y. Tsujimoto,et al.  Another way to die: autophagic programmed cell death , 2005, Cell Death and Differentiation.

[17]  P. Agostinis,et al.  Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. , 2005, Biochimica et biophysica acta.

[18]  Guido Kroemer,et al.  Caspase-independent cell death , 2005, Nature Medicine.

[19]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[20]  S. Clouthier,et al.  Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. , 2005, Blood.

[21]  J. Roujeau,et al.  Evaluation of the potential role of cytokines in toxic epidermal necrolysis. , 2004, The Journal of investigative dermatology.

[22]  P. Agostinis,et al.  AKT status controls susceptibility of malignant keratinocytes to the early-activated and UVB-induced apoptotic pathway. , 2004, The Journal of investigative dermatology.

[23]  A. Kimchi,et al.  Autophagy as a cell death and tumor suppressor mechanism , 2004, Oncogene.

[24]  Albert J Fornace,et al.  p38 Mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses. , 2004, The Journal of investigative dermatology.

[25]  L. Lo Muzio,et al.  Apoptosis: escaping strategies in human skin cancer (Review). , 2004, Oncology reports.

[26]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[27]  G. Salvesen,et al.  Mechanisms of caspase activation. , 2003, Current opinion in cell biology.

[28]  M. V. D. van den Brink,et al.  Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. , 2003, Blood.

[29]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[30]  Jennifer Y. Zhang,et al.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. , 2003, Nature.

[31]  R. S. Padilla,et al.  Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. , 2003, Archives of dermatology.

[32]  Martine Bagot,et al.  Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. , 2002, The Journal of investigative dermatology.

[33]  F. Bachmann,et al.  Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. , 2001, The Journal of investigative dermatology.

[34]  N. Chao,et al.  Pathophysiologic mechanisms of acute graft-vs.-host disease. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[35]  F. McKeon,et al.  Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. , 1999, The Journal of investigative dermatology.

[36]  J. McNiff,et al.  Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[37]  M. Kripke,et al.  Fas ligand: a sensor for DNA damage critical in skin cancer etiology. , 1999, Science.

[38]  Y. Aizawa,et al.  Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation , 1999 .

[39]  J. Tschopp,et al.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. , 1998, Science.

[40]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[41]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[42]  Thomas A. Luger,et al.  Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L , 1998, The Journal of cell biology.

[43]  A. Ziegler,et al.  Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. , 1996, The journal of investigative dermatology. Symposium proceedings.

[44]  J. Roujeau,et al.  Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis , 1996, The British journal of dermatology.